Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17 beta-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
Journal Article
·
· Journal of Medicinal Chemistry
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE SC OFFICE OF SCIENCE (SC)
- DOE Contract Number:
- DE-AC02-98CH10886
- OSTI ID:
- 1109994
- Report Number(s):
- BNL-103128-2013-JA
- Journal Information:
- Journal of Medicinal Chemistry, Vol. 56, Issue 6; ISSN 0022--2623
- Country of Publication:
- United States
- Language:
- English
Similar Records
Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
PURIFICATION, CRYSTALLIZATION AND PRELIMINARY X RAY STRUCTURAL RESULTS OF HUMAN 17 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 5
Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer
Journal Article
·
Wed Mar 13 00:00:00 EDT 2013
· Journal of Medicinal Chemistry
·
OSTI ID:1109994
+5 more
PURIFICATION, CRYSTALLIZATION AND PRELIMINARY X RAY STRUCTURAL RESULTS OF HUMAN 17 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 5
Journal Article
·
Tue Jan 01 00:00:00 EST 2002
· J. BIOL. CHEM.
·
OSTI ID:1109994
+2 more
Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer
Journal Article
·
Thu Mar 15 00:00:00 EDT 2012
· BioOrganic and Medicinal Chemistry Letters
·
OSTI ID:1109994
+3 more